2022
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
ARKADIUSZ, Dziedzic, Julien ISSA, Mohammad Salman HUSSAIN, Tanasiewicz MARTA, Wojtyczka ROBERT et. al.Základní údaje
Originální název
COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study
Autoři
ARKADIUSZ, Dziedzic, Julien ISSA, Mohammad Salman HUSSAIN (356 Indie, domácí), Tanasiewicz MARTA, Wojtyczka ROBERT, Kubina ROBERT, Konwinska Marta DYSZKIEWICZ a Abanoub RIAD (818 Egypt, garant, domácí)
Vydání
Frontiers in Public Health, LAUSANNE, FRONTIERS MEDIA SA, 2022, 2296-2565
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.200
Kód RIV
RIV/00216224:14110/22:00126335
Organizační jednotka
Lékařská fakulta
UT WoS
000891406400001
Klíčová slova anglicky
cross-sectional studies; COVID-19 vaccines; decision making; healthcare professionals; vaccination hesitancy; Poland
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 5. 4. 2023 08:17, Mgr. Tereza Miškechová
Anotace
V originále
Since healthcare professionals (HCPs) play a critical role in shaping their local communities' attitudes toward vaccines, HCPs' beliefs and attitudes toward vaccination are of vital importance for primary prevention strategies. The present study was designed as a cross-sectional survey-based study utilizing a self-administered questionnaire to collect data about COVID-19 vaccine booster hesitancy (VBH) among Polish HCPs and students of medical universities (MUSs). Out of the 443 included participants, 76.3% were females, 52.6% were HCPs, 31.8% were previously infected by SARS-CoV-2, and 69.3% had already received COVID-19 vaccine booster doses (VBD). Overall, 74.5% of the participants were willing to receive COVID-19 VBD, while 7.9 and 17.6% exhibited their hesitance and rejection, respectively. The most commonly found promoter for acceptance was protection of one's health (95.2%), followed by protection of family's health (81.8%) and protection of community's health (63.3%). Inferential statistics did not show a significant association between COVID-19 VBH and demographic variables, e.g., age and gender; however, the participants who had been previously infected by SARS-CoV-2 were significantly more inclined to reject the VBD. Protection from severe infection, community transmission, good safety profile, and favorable risk-benefit ratio were the significant determinants of the COVID-19 VBD acceptance and uptake. Fear of post-vaccination side effects was one of the key barriers for accepting COVID-19 VBD, which is consistent with the pre-existing literature. Public health campaigns need to highlight the postulated benefits of vaccines and the expected harms of skipping VBD.
Návaznosti
EF18_053/0016952, projekt VaV |
| ||
EF19_073/0016943, projekt VaV |
| ||
MUNI/A/1402/2021, interní kód MU |
| ||
MUNI/IGA/1104/2021, interní kód MU |
|